ID26485A - PAROXOXINE COMPOSITION - Google Patents

PAROXOXINE COMPOSITION

Info

Publication number
ID26485A
ID26485A IDW20001883A ID20001883A ID26485A ID 26485 A ID26485 A ID 26485A ID W20001883 A IDW20001883 A ID W20001883A ID 20001883 A ID20001883 A ID 20001883A ID 26485 A ID26485 A ID 26485A
Authority
ID
Indonesia
Prior art keywords
paroxoxine
composition
paroxoxine composition
Prior art date
Application number
IDW20001883A
Other languages
Indonesian (id)
Inventor
Craig Andrew Simon
Ward Neal
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID26485A publication Critical patent/ID26485A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
IDW20001883A 1998-03-24 1999-03-24 PAROXOXINE COMPOSITION ID26485A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9806312.6A GB9806312D0 (en) 1998-03-24 1998-03-24 Novel formulations

Publications (1)

Publication Number Publication Date
ID26485A true ID26485A (en) 2001-01-11

Family

ID=10829181

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001883A ID26485A (en) 1998-03-24 1999-03-24 PAROXOXINE COMPOSITION

Country Status (20)

Country Link
EP (1) EP1063993A1 (en)
JP (1) JP2002507569A (en)
CN (1) CN1125639C (en)
AP (1) AP2000001914A0 (en)
AU (1) AU754765B2 (en)
BG (1) BG104865A (en)
BR (1) BR9908991A (en)
CA (1) CA2324612A1 (en)
EA (1) EA003393B1 (en)
GB (1) GB9806312D0 (en)
HU (1) HUP0101326A3 (en)
ID (1) ID26485A (en)
IL (1) IL138478A0 (en)
NO (1) NO313404B1 (en)
NZ (1) NZ506893A (en)
PL (1) PL343095A1 (en)
SK (1) SK14102000A3 (en)
TR (1) TR200002750T2 (en)
WO (1) WO1999048499A1 (en)
ZA (1) ZA200005697B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
DK200100341A (en) * 2001-03-02 2002-09-03 Gea Farmaceutisk Fabrik As Process for the preparation of pharmaceutical tablets containing paroxetine hydrochloride anhydrate
CA2531097C (en) * 2003-07-02 2012-10-09 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
HU1000278D0 (en) * 2010-05-28 2010-07-28 Egis Gyogyszergyar Nyilvanosan Novel pharmaceutical use uf silicic acid
CN103961333B (en) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 Paroxetine mesylate capsule and preparation method thereof
CN104027306A (en) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 Paroxetine oral suspension and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
AR001982A1 (en) * 1995-02-06 1998-01-07 Smithkline Beecham Plc PAROXETINE CHLORHYDRATE ANHYDRATED, AND PROCEDURE FOR ITS PREPARATION
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride

Also Published As

Publication number Publication date
CN1294512A (en) 2001-05-09
NO313404B1 (en) 2002-09-30
ZA200005697B (en) 2001-10-02
BR9908991A (en) 2000-12-12
TR200002750T2 (en) 2000-12-21
HUP0101326A2 (en) 2002-05-29
EA200000977A1 (en) 2001-02-26
PL343095A1 (en) 2001-07-30
EA003393B1 (en) 2003-04-24
WO1999048499A1 (en) 1999-09-30
AU754765B2 (en) 2002-11-21
IL138478A0 (en) 2001-10-31
CN1125639C (en) 2003-10-29
AU3045199A (en) 1999-10-18
SK14102000A3 (en) 2001-03-12
GB9806312D0 (en) 1998-05-20
JP2002507569A (en) 2002-03-12
NO20004740D0 (en) 2000-09-22
HUP0101326A3 (en) 2002-06-28
CA2324612A1 (en) 1999-09-30
BG104865A (en) 2001-05-31
AP2000001914A0 (en) 2000-09-30
EP1063993A1 (en) 2001-01-03
NO20004740L (en) 2000-10-03
NZ506893A (en) 2003-06-30

Similar Documents

Publication Publication Date Title
ID26186A (en) SAMPO COMPOSITION
ID28694A (en) SAMPO COMPOSITION
ID29430A (en) HERBISIDE COMPOSITION
ID26926A (en) SHAMPO COMPOSITION FORM MODE
ID26549A (en) EPOTILON COMPOSITIONS
ATE367793T1 (en) SWEAT-INHIBITING COMPOSITIONS
FI981011L (en) New compositions
ATE469550T1 (en) ANTIPARASIC COMPOSITIONS
DE69919953D1 (en) FUNCTIONAL COMPOSITIONS
ID25508A (en) DEMATOLOGICAL COMPOSITION
DE69927758D1 (en) Imidosilane compositions
ID23458A (en) NEFAZODON AVAILABLE FORM
DE69942892D1 (en) GAS-CREATING COMPOSITION
DE69928862D1 (en) composition
ID23761A (en) SUBSTITUTED TRISICLIC
ID27889A (en) POLYCLIC COOPOLYMER COMPOSITIONS
ID23250A (en) PAROXSETIN COMPOSITION
ID21906A (en) ADESIVE COMPOSITION
ID23219A (en) SUBSTITUTED TRISICLIC
DE69809804D1 (en) NOTLAUFGELÄNDEREIFEN
NO996073D0 (en) Hockeykoelle
DE59807217D1 (en) NADELLAGER
ID26295A (en) HARD-ULTRAVIOLET COMPOSITION
NO20005483L (en) New composition
FI980759A0 (en) Taetningskonstruktion Foer suglaodan i en sugvals